Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/reperfusion-induced myocardial injury. [electronic resource]
Producer: 20050411Description: 554-62 p. digitalISSN:- 0012-1797
- Administration, Oral
- Animals
- Blood Glucose -- drug effects
- Coronary Vessels -- physiopathology
- Diabetes Mellitus, Type 2 -- drug therapy
- Fatty Acids, Nonesterified -- blood
- Heart -- drug effects
- Hypoglycemic Agents -- therapeutic use
- Insulin Resistance -- physiology
- Male
- Myocardial Infarction -- pathology
- Myocardial Reperfusion Injury -- prevention & control
- Myocardium -- metabolism
- Rats
- Rats, Zucker
- Rosiglitazone
- Thiazolidinediones -- therapeutic use
- Triglycerides -- blood
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.